5Flynn EA, Pearson RE, Barker KN. Observational study of accuracy in compounding iv. admixtures at five hospitals [J]. Am J Health Syst Pharm, 1997, 54(8): 904.
4Robert J. Cipolle, Linda M. Strand. Pharmaceutical Care Practice.Minneapolis, Minnesota:University of Minesota; 1998.
5Hepler, CD. strand, LM. Oportunitities and responsibilities in pharmaceutical care[J]. Am J Hosp Pharms 1990,47:533-543.
6Dougherry, CJ. Back to Reform : Values, Markets, and the Health Care System. Oxford,England: Oxford University Press; 1996.
7Mikeal,RL,Brown,TP,Lazarus,HL,et al. Quality of pharmaceutical care in hospitals[J]. Am J Hosp Pharm, 1975,32:567-574.
8Richard J. Plumridge and Michael Maher. Justification of a pharmacy intravenous admixture service in an Australian hospital[J],Am J Hosp Pharm, 1993,50(3) :463.
9American Society of Hospital Pharmacists. ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs. Am J Hosp Pharm, 1990,47:1 033-1 034.
10Occupational Safety and Health Administration U.S. Department of Labor. Technical Links>Osha Technical Manual. Controlling occupational exposure to hazardous drugs. 1993.
